TY  - JOUR

T1  - Safety and Efficacy of Treatment with Dupilumab for up to 2 Years in Infants and Young Children with Atopic Dermatitis

JO  - American Journal of Clinical Dermatology

PY  - 2026/03/28

AU  - Paller AS

AU  - Simpson EL

AU  - Siegfried EC

AU  - Cork MJ

AU  - Arkwright PD

AU  - Pinter A

AU  - Deleuran M

AU  - Hong HCH

AU  - Ma Y

AU  - Bansal A

AU  - Dubost-Brama A et al

ED  - 

DO  - DOI: 10.1007/s40257-026-01018-1

Y2  - 2026/04/10

ER  -